Skip to main content
Premium Trial:

Request an Annual Quote

Ventana, ImmunoGen Team up in CDx Deal

NEW YORK (GenomeWeb) – Roche's Ventana Medical Systems today announced a deal with ImmunoGen to develop an immunohistochemistry-based companion diagnostic test for the oncology therapeutic firm's product candidates.

The companies have initially developed a test for folate receptor alpha, FRa, also known as folate receptor 1, or FOL1. The test is being used in early trials for ImmunoGen's FRa-targeting antibody conjugate IMGN853. Cancers that highly express FRa include epithelial ovarian cancer, endometrial cancer, and types of non-small cell lung cancer.

Ventana and ImmunoGen said that the collaboration leverages Ventana's expertise in companion diagnostic development, from prototyping through regulatory approval and commercialization in order to identify patient populations that may benefit from ImmunoGen's targeted therapies.

Financial and other terms of the agreement were not disclosed.

Ventana noted that it is currently involved in more than 180 collaborations to develop and commercialize companion diagnostics. Most recently it inked a deal with Quintiles to offer companion diagnostic testing services to drug developers in early stage oncology studies in China. Ventana also has CDx deals with Merck KGaA for an undisclosed therapeutic target and with MedImmune for a non-small cell lung cancer target.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.